Bowman and Brooke Logo

INSIGHTS

Bowman and Brooke lawyers speak regularly at legal education conferences and industry associations. They write for professional and industry publications, providing thought leadership on legal topics and industry trends.
February 11, 2014

Michigan Drug Companies Now Less Immune Under Tort Reform

Related Topics
Heart monitor and pill icon - drug and medical device

On January 21, 2014, the U.S. Court of Appeals for the Sixth Circuit ruled that manufacturers and sellers of "combination products"—that is, products which have attributes of both pharmaceuticals and medical devices—are not statutorily immune from liability under Michigan's Tort Reform statute. In an article for Law360, Partners Kim Schmid and Jeffrey Gorcyca discuss the ramifications of the decision.

Read the Law360 article.

Related:

Related Practices

The Legal 500

Recognized for the eleventh consecutive year in “Product liability, mass tort and class action: pharmaceuticals and medical devices - defense.”